Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Magnificent Ventures is a venture capital firm focused on bridging innovation and impact. Founded with a mission to enhance human health and address societal issues, it donates 80% of profits from carried interest to initiatives like the Root Cause Project. The firm invests across seed to pre-IPO stages and has a notable portfolio company in CoRegen.
This firm invests in visionary ideas within food-agtech, climate, and healthcare sectors. Targeting seed to pre-IPO stages, Magnificent Ventures aims to generate resources that tackle pressing global challenges. Check sizes and specific investment amounts are not disclosed.
One notable portfolio company is CoRegen, which is developing a cancer treatment using CRISPR gene editing technology. Their pre-clinical studies have shown promising results in eliminating cancer in mice.
Submit your pitch through their website's contact form.
Yes, Magnificent Ventures often leads investment rounds, particularly in seed-stage companies.
The firm is open to follow-on investments, especially if the portfolio company aligns with their mission and shows significant progress.
The specific size of the current fund is not publicly disclosed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.